Acifar Cream Acyclovir
PRODUCT DESCRIPTION
| Manufacturer | Ifars | |||||||||||||||||||||||||||
| Contents | Acyclovir | |||||||||||||||||||||||||||
| Indications/Uses | Herpes simplex infections in skin & mucous membrane, including initial & recurrent genital & labial herpes. | |||||||||||||||||||||||||||
| Dosage/Directions for Use | Apply 5 times daily 4 hrly w/o night dose. Duration of treament: 5 days, may be continued until 10 days. | |||||||||||||||||||||||||||
| Contraindications | Hypersensitivity. | |||||||||||||||||||||||||||
| Special Precautions | Do not apply to mucous membrane. Not for prevention of recurrent herpes simplex infection. Pregnancy & lactation. Childn. | |||||||||||||||||||||||||||
| Adverse Reactions | Burning & stinging. Erythema, mild dry skin, skin flaking. | |||||||||||||||||||||||||||
| View ADR Monitoring Form | ||||||||||||||||||||||||||||
|
Increased t½ w/ probenecid. | |||||||||||||||||||||||||||
| Preg Safety (US) | ||||||||||||||||||||||||||||
| Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). | ||||||||||||||||||||||||||||
| MIMS Class | Topical Antivirals | |||||||||||||||||||||||||||
| ATC Classification | D06BB03 - aciclovir ; Belongs to the class of topical antivirals used in the treatment of dermatological diseases. | |||||||||||||||||||||||||||
| Regulatory Classification | G | |||||||||||||||||||||||||||
| Form | Packing | |||||||||||||||||||||||||||
| Acifar cream 5 % | 5gx1's | |||||||||||||||||||||||||||
